NCT00984074 MRI Mapping in Planning Radiation Therapy to the Base of Skull and Brain in Patients With Nonmetastatic Head and Neck Cancer Status COMPLETED Phase N/A
NCT00983697 FDG-PET/CT in Assessing the Tumor and Planning Neck Surgery in Patients With Newly Diagnosed H&N Cancer Status UNKNOWN Phase NA
NCT00978081 Photodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck Tumors Status COMPLETED Phase PHASE1
NCT00973947 Customized Headrest or Standard Headrest in Holding Patients Still While Undergoing Radiation Therapy for Head and Neck Cancer Status COMPLETED Phase NA
NCT00971867 Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00968656 Assessment of Cellular Proliferation in Tumors by Positron Emission Tomography (PET) Using [18F]ISO-1 Status COMPLETED Phase PHASE1
NCT00968435 Bevacizumab, Cetuximab, and Cisplatin With IMRT (Intensity-Modulated Radiation Therapy) for Patients With Stage III/IV Head and Neck Squamous Cell Carcinoma Status COMPLETED Phase PHASE2
NCT00967577 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT00963326 Study of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity Cancer Status UNKNOWN Phase N/A
NCT00956007 RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT00951470 Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema Status WITHDRAWN Phase NA
NCT00942734 Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell Carcinoma Status COMPLETED Phase PHASE2
NCT00937417 S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors Status WITHDRAWN Phase PHASE1
NCT00928161 Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy Status WITHDRAWN Phase NA